A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
Bristol-Myers Squibb
Bristol-Myers Squibb
Autolus Limited
Bristol-Myers Squibb
SymBio Pharmaceuticals
M.D. Anderson Cancer Center
Princess Maxima Center for Pediatric Oncology
Turning Point Therapeutics, Inc.
M.D. Anderson Cancer Center
City of Hope Medical Center
Columbia University
Takeda
University of Nebraska
University of Nebraska
City of Hope Medical Center
Massachusetts General Hospital
Columbia University
Memorial Sloan Kettering Cancer Center
Northwestern University
Takeda
Mayo Clinic
Columbia University
Children's Oncology Group
Mayo Clinic
Takeda
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
National Cancer Institute (NCI)
University of Washington
National Cancer Institute (NCI)
University of Washington
National Cancer Institute (NCI)
Samsung Medical Center
Peking University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Asan Medical Center
M.D. Anderson Cancer Center
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center